USRE35849E - Indwelling stent - Google Patents

Indwelling stent Download PDF

Info

Publication number
USRE35849E
USRE35849E US08/367,801 US36780194A USRE35849E US RE35849 E USRE35849 E US RE35849E US 36780194 A US36780194 A US 36780194A US RE35849 E USRE35849 E US RE35849E
Authority
US
United States
Prior art keywords
end portion
stent
drainage tube
duct
inflow end
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/367,801
Inventor
Nib Soehendra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cook Medical Technologies LLC
Original Assignee
Wilson Cook Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wilson Cook Medical Inc filed Critical Wilson Cook Medical Inc
Priority to US08/367,801 priority Critical patent/USRE35849E/en
Application granted granted Critical
Publication of USRE35849E publication Critical patent/USRE35849E/en
Assigned to COOK MEDICAL TECHNOLOGIES LLC reassignment COOK MEDICAL TECHNOLOGIES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WILSON-COOK MEDICAL INCORPORATED, COOK VASCULAR INCORPORATED, SABIN CORPORATION, COOK INCORPORATED, VANCE PRODUCTS INCORPORATED
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/94Stents retaining their form, i.e. not being deformable, after placement in the predetermined place
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • A61M27/002Implant devices for drainage of body fluids from one part of the body to another
    • A61M27/008Implant devices for drainage of body fluids from one part of the body to another pre-shaped, for use in the urethral or ureteral tract
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/005Rosette-shaped, e.g. star-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0058X-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02Holding devices, e.g. on the body
    • A61M25/04Holding devices, e.g. on the body in the body, e.g. expansible

Definitions

  • the field of the invention is indwelling stents which aid in the drainage of fluids within the body.
  • a number of various stents have been devised which are designed to aid in the drainage of fluids within the body. It is generally desirable that a stent being implanted for this purpose be easily implantable, that it maintain patency of the duct and its position within the duct after implantation, that reflux or backflow through the duct be avoided, and that the stent be easily removable.
  • Stents have been designed in a wide variety of shapes and sizes to effectuate these general requirements.
  • U.S. Pat. No. 5,052,998 to Zimmon discloses an indwelling stent having flaps at its inflow end and a pigtail configuration at its outflow end to facilitate anchoring of the stent within the duct to be drained, and also has a series of drainage holes along its length to facilitate drainage.
  • Other stents mentioned in the Zimmon patent have commonly employed double flaps, or wings, or have incorporated pigtails on both ends, to hold the stent in place.
  • Prior art stents have been provided both with and without the drainage holes shown in the Zimmon patent.
  • Reflux is the condition where fluids and/or debris are drawn backwardly up into the duct to be drained. This is undesirable in that it is counterproductive to the purpose of the stent being implanted to drain the duct. Reflux of debris into the stent can also potentially occlude the implanted stent within the duct, which can potentially cause severe aggravation to the condition being treated. Reflux is normally prevented by the functioning of a sphincter located where the duct exits into its receiving organ, however this sphincter operation is inhibited by the placement of an indwelling stent which acts to maintain the patency of the sphincter as well as the duct being drained.
  • U.S. Pat. No. 5,019,102 to Hoene discloses a stent with a dynamic hood-valve at the vesical end of the stent, located within the receiving organ at the downflow end of the obstructed duct.
  • the hood-valve is comprised of a hood-shaped plastic foil that is attached to and partially surrounds the vesical end opening.
  • a reflux pressure causes the hood-valve to fold over to close the vesical opening, thereby preventing retrograde flow from occurring.
  • U.S. Pat. No. 4,671,795 to Mulchin discloses one such example of an indwelling stent which has a suture attached to its end which extends out of the body and is tied to a button outside the body. The button prevents upward migration and may be pulled to remove the stent from the body.
  • U.S. Pat. No. 4,913,683 to Gregory is another reference disclosing a stent system which utilizes sutures that extend outwardly of the patient and are pulled to remove the stent from the body.
  • Zilber suggests the use of trailing sutures as an aid in the positioning of a stent being implanted.
  • Zimmon suggests drawing the end of a large diameter stent (10 French or greater) to a reduced diameter to facilitate removal col. 3, lines 52-57! in an effort to compensate for the fact that larger diameter stents are more difficult to grasp and remove.
  • the present invention generally provides a new and unique indwelling stent which facilitates the drainage of fluids through a duct within the body.
  • a stent according to the present invention acts to enhance drainage while preventing reflux by allowing the sphincter at the exit of the duct to function normally.
  • the stent is also easily removed when needed.
  • a double wing stent having multiple flaps at each end and a continuous uninterrupted drainage tube therebetween, is implantable within an obstructed duct.
  • a "wick" Located at the outflow end of the drainage tube of the stent is a "wick" which is made of an extended arcical section of the drainage tube.
  • the stent when implanted with the outflow end of its drainage tube within the duct, prevents reflux by allowing the sphincter at the exit of the duct to function normally.
  • the wick In this operative position, the wick extends through the remaining section of the duct and into the receiving organ.
  • the wick serves to enhance drainage by providing a "wicking" effect for fluid as it exits the stent's outflow end and, with the outflow end of the drainage tube wholly within the duct, the sphincter at the exit of the duct is allowed to function normally, thereby preventing reflux.
  • the implanted stent tends to remain unobstructed for longer periods of time and therefore is safer for the patient and may remain in place without the need for replacement for longer periods.
  • the wick further serves to facilitate removal by providing an exposed portion which is easily graspable by an instrument inserted into the body to retain and remove the stent.
  • FIGS. 1a-d are various illustrations of a stent according to the present invention.
  • FIG. 1a is a side elevational view of a stent for facilitating the drainage of fluids within an obstructed duct.
  • FIG. 1b is a top plan view of the stent 10 of FIG. 1a.
  • FIG. 1c is a perspective view of the out flow end of stent 10, while FIGS. 1-d is an end view of the outflow end of this stent.
  • FIGS. 2a-b are illustrations of the stent of FIGS. 1a-d implanted within an obstructed duct to aid in the drainage of fluids therethrough.
  • FIGS. 2a-b show the stent implanted within the duct, with the outflow end of its drainage tube wholly within the duct, and its wick extending through the exit of the duct and into the receiving organ.
  • the sphincter at the exit of the duct is open to allow the free flow of fluid out of the duct and into the receiving organ.
  • the sphincter is closed to prevent the reflux of fluid and/or debris back into the duct.
  • FIGS. 1a-d are various illustrations of a stent of the present invention, which will now be described with reference to these figures.
  • Stent 10 is made of radiopaque polyethylene and has an inflow, end portion 11 and an outflow end portion 12, and a drainage tube 13 therebetween.
  • Inflow end portion 11 defines inlet I for allowing fluid to enter into drainage tube 13, while outflow, end portion 12 defines outlet O for allowing fluid to exit drainage tube 13.
  • At inflow end 11 are two alternating rows of four radially extending flaps 11a which serve to aid in the anchoring of stent 10 within an obstructed duct.
  • radially extending flaps 12a are located at outflow end portion 12 of stent 10, except that only one row of four flaps 12a, as shown, are incorporated at outflow end portion 12 for the prevention upward migration.
  • the number, size, and orientation of flaps 11a and 12a may be modified to accommodate the mitration-preventing requirements of the particular stent to be implanted.
  • Flaps 11a and 12a are simply constructed by slicing small longitudinal sections in stent 10 and orienting the sliced sections radially. It is preferred that the above described slices are made shallowly such that holes are not made within the drainage tube by the construction of flaps 11a and 12a.
  • Drainage tube 13 is comprised of a continuously uninterupted tube and provides a drainage passageway though an obstructed duct when stent 10 has been implanted therein. Drainage tube 13 has a 120° bend 13a at approximately one third of its overall length from outlet O. Bend 13a is incorporated in stent 10 to accommodate the anatomical structure of the duct into which stent 10 is to be implanted, which by this example is the biliary duct.
  • Wick 12b located at outflow end 12 of stent 10, is comprised of an extended arcical section of drainage tube 13 and serves to enhance drainage by providing a "wicking" effect for fluid as it exits outlet O. Wick 12b further serves to allow stent 10 to be implanted with its outflow end 12 positioned within duct 20 rather than extending into the receiving organ 30, thereby allowing sphincter 21 at the exit of duct 20 to function normally to prevent reflux. Additionally, wick 12b serves to facilitate removal by providing an exposed portion, extending through sphincter 21 and into receiving organ 30, which is easily graspable by an instrument inserted into the body to retain and remove stent 10.
  • wick 12b has an arcical cross-section of about 70° which is intended for illustrative purposes.
  • Arcical cross-sections of wider or narrower dimension than specifically disclosed herein may serve to provide the intended and described novel functions of wick 12b and, as such, are considered to fall within the scope of this invention.
  • FIGS. 2a-b illustrate the stent of FIGS. 1a-d implanted within an obstructed duct 20 to aid in the drainage of fluids therethrough.
  • flaps 11a and 12a serve to anchor stent 10 in place within duct 20 and prevent undesirable migration.
  • Drainage tube 13 maintains patency within duct 20, thereby allowing fluids to flow therethrough.
  • Wick 12b provides a wicking effect which enhances the further flow of fluid upon exiting drainage tube 13 at outlet O, while also allowing sphincter 21 to function normally, thereby serving to reduce the possible occurrence of reflux.
  • sphincter 21 The normal operation of sphincter 21 is illustrated by the comparison of FIGS. 2a and b.
  • sphincter 21 is opened to allow the free flow of fluid away from duct 20.
  • wick 12b enhances drainage by providing a wicking effect for fluid as it exits the outflow end of drainage tube 13.
  • sphincter 21 is closed to prevent reflux from occurring.
  • sphincter 21 closes about wick 12b to effectuate closure.
  • wick 12b also serves the function of facilitating such removal by providing an exposed portion which is easily graspable by forceps or other instrument inserted for removal.

Abstract

An indwelling stent is disclosed which facilitates the drainage of fluids through a duct within the body, and which is easily removed when needed. The disclosed stent is a double wing stent and includes multiple flaps at each end for anchoring and has a continuously uninterrupted drainage tube therebetween. Constructed at the outflow end of the stent is a wick, which is made of an extended arcical section of the drainage tube of the stent and serves to enhance drainage by providing a "wicking" effect for fluid as it exits the stent's outflow end, while inhibiting reflux by allowing for the sphincter at the exit of the obstructed duct to function in a normal manner. The wick further serves to facilitate removal by providing a portion which is easily graspable by an instrument inserted into the body for retention and removal.

Description

BACKGROUND OF THE INVENTION
1. Field of the Invention
The field of the invention is indwelling stents which aid in the drainage of fluids within the body.
2. Description of the Prior Art
A number of various stents have been devised which are designed to aid in the drainage of fluids within the body. It is generally desirable that a stent being implanted for this purpose be easily implantable, that it maintain patency of the duct and its position within the duct after implantation, that reflux or backflow through the duct be avoided, and that the stent be easily removable.
Stents have been designed in a wide variety of shapes and sizes to effectuate these general requirements. One such example is shown by U.S. Pat. No. 5,052,998 to Zimmon which discloses an indwelling stent having flaps at its inflow end and a pigtail configuration at its outflow end to facilitate anchoring of the stent within the duct to be drained, and also has a series of drainage holes along its length to facilitate drainage. Other stents mentioned in the Zimmon patent, have commonly employed double flaps, or wings, or have incorporated pigtails on both ends, to hold the stent in place. Prior art stents have been provided both with and without the drainage holes shown in the Zimmon patent.
Reflux is the condition where fluids and/or debris are drawn backwardly up into the duct to be drained. This is undesirable in that it is counterproductive to the purpose of the stent being implanted to drain the duct. Reflux of debris into the stent can also potentially occlude the implanted stent within the duct, which can potentially cause severe aggravation to the condition being treated. Reflux is normally prevented by the functioning of a sphincter located where the duct exits into its receiving organ, however this sphincter operation is inhibited by the placement of an indwelling stent which acts to maintain the patency of the sphincter as well as the duct being drained.
To prevent reflux, U.S. Pat. No. 5,019,102 to Hoene discloses a stent with a dynamic hood-valve at the vesical end of the stent, located within the receiving organ at the downflow end of the obstructed duct. The hood-valve is comprised of a hood-shaped plastic foil that is attached to and partially surrounds the vesical end opening. A reflux pressure causes the hood-valve to fold over to close the vesical opening, thereby preventing retrograde flow from occurring.
Some stents have been devised which terminate within the duct to be drained to allow for normal sphincter operation. U.S. Pat. No. 4,955,859 to Zilber is one such example which suggests the use of a ureteral stent which terminates within the urethra to allow for the normal operation of the external sphincter in order to prevent incontinence.
It is known in the prior art to incorporate means for facilitating the removal of an indwelling stent from the body. U.S. Pat. No. 4,671,795 to Mulchin discloses one such example of an indwelling stent which has a suture attached to its end which extends out of the body and is tied to a button outside the body. The button prevents upward migration and may be pulled to remove the stent from the body. U.S. Pat. No. 4,913,683 to Gregory is another reference disclosing a stent system which utilizes sutures that extend outwardly of the patient and are pulled to remove the stent from the body. Zilber suggests the use of trailing sutures as an aid in the positioning of a stent being implanted. Zimmon suggests drawing the end of a large diameter stent (10 French or greater) to a reduced diameter to facilitate removal col. 3, lines 52-57! in an effort to compensate for the fact that larger diameter stents are more difficult to grasp and remove.
SUMMARY OF THE INVENTION
The present invention generally provides a new and unique indwelling stent which facilitates the drainage of fluids through a duct within the body. When implanted within an obstructed duct to be drained, a stent according to the present invention acts to enhance drainage while preventing reflux by allowing the sphincter at the exit of the duct to function normally. The stent is also easily removed when needed. According to the preferred embodiment disclosed herein, a double wing stent, having multiple flaps at each end and a continuous uninterrupted drainage tube therebetween, is implantable within an obstructed duct. Located at the outflow end of the drainage tube of the stent is a "wick" which is made of an extended arcical section of the drainage tube.
The stent, when implanted with the outflow end of its drainage tube within the duct, prevents reflux by allowing the sphincter at the exit of the duct to function normally. In this operative position, the wick extends through the remaining section of the duct and into the receiving organ. The wick serves to enhance drainage by providing a "wicking" effect for fluid as it exits the stent's outflow end and, with the outflow end of the drainage tube wholly within the duct, the sphincter at the exit of the duct is allowed to function normally, thereby preventing reflux. In this way, the implanted stent tends to remain unobstructed for longer periods of time and therefore is safer for the patient and may remain in place without the need for replacement for longer periods. The wick further serves to facilitate removal by providing an exposed portion which is easily graspable by an instrument inserted into the body to retain and remove the stent.
It is an object of the present invention to provide an improved stent for the drainage of fluids within the body.
It a further object of the present invention to provide such a stent which facilitates drainage within an obstructed duct while allowing the sphincter at the exit of the duct to function normally to inhibit reflux.
It a further object of the present invention to provide such a stent which is easy to remove when needed.
It is yet another object to provide such a stent which has the advantage of simplicity of construction.
These and other objects and advantages will be apparent from a review of the following specification and claims.
BRIEF DESCRIPTION OF THE DRAWINGS
FIGS. 1a-d are various illustrations of a stent according to the present invention. FIG. 1a is a side elevational view of a stent for facilitating the drainage of fluids within an obstructed duct. FIG. 1b is a top plan view of the stent 10 of FIG. 1a. FIG. 1c is a perspective view of the out flow end of stent 10, while FIGS. 1-d is an end view of the outflow end of this stent.
FIGS. 2a-b are illustrations of the stent of FIGS. 1a-d implanted within an obstructed duct to aid in the drainage of fluids therethrough. FIGS. 2a-b show the stent implanted within the duct, with the outflow end of its drainage tube wholly within the duct, and its wick extending through the exit of the duct and into the receiving organ. In FIG. 2a, the sphincter at the exit of the duct is open to allow the free flow of fluid out of the duct and into the receiving organ. In FIG. 2b, the sphincter is closed to prevent the reflux of fluid and/or debris back into the duct.
DESCRIPTION OF THE PREFERRED EMBODIMENT
For the purposes of promoting an understanding of the principles of the invention, reference will now be made to the embodiment illustrated in the drawings and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended, such alterations and further modifications in the illustrated device, and such further applications of the principles of the invention as illustrated therein being contemplated as would normally occur to one skilled in the art to which the invention relates.
FIGS. 1a-d are various illustrations of a stent of the present invention, which will now be described with reference to these figures. Stent 10 is made of radiopaque polyethylene and has an inflow, end portion 11 and an outflow end portion 12, and a drainage tube 13 therebetween. Inflow end portion 11 defines inlet I for allowing fluid to enter into drainage tube 13, while outflow, end portion 12 defines outlet O for allowing fluid to exit drainage tube 13. At inflow end 11 are two alternating rows of four radially extending flaps 11a which serve to aid in the anchoring of stent 10 within an obstructed duct. In the same manner and for the same purpose, radially extending flaps 12a are located at outflow end portion 12 of stent 10, except that only one row of four flaps 12a, as shown, are incorporated at outflow end portion 12 for the prevention upward migration. The number, size, and orientation of flaps 11a and 12a may be modified to accommodate the mitration-preventing requirements of the particular stent to be implanted.
Flaps 11a and 12a are simply constructed by slicing small longitudinal sections in stent 10 and orienting the sliced sections radially. It is preferred that the above described slices are made shallowly such that holes are not made within the drainage tube by the construction of flaps 11a and 12a.
Drainage tube 13 is comprised of a continuously uninterupted tube and provides a drainage passageway though an obstructed duct when stent 10 has been implanted therein. Drainage tube 13 has a 120° bend 13a at approximately one third of its overall length from outlet O. Bend 13a is incorporated in stent 10 to accommodate the anatomical structure of the duct into which stent 10 is to be implanted, which by this example is the biliary duct.
Wick 12b, located at outflow end 12 of stent 10, is comprised of an extended arcical section of drainage tube 13 and serves to enhance drainage by providing a "wicking" effect for fluid as it exits outlet O. Wick 12b further serves to allow stent 10 to be implanted with its outflow end 12 positioned within duct 20 rather than extending into the receiving organ 30, thereby allowing sphincter 21 at the exit of duct 20 to function normally to prevent reflux. Additionally, wick 12b serves to facilitate removal by providing an exposed portion, extending through sphincter 21 and into receiving organ 30, which is easily graspable by an instrument inserted into the body to retain and remove stent 10.
In the embodiment shown, wick 12b has an arcical cross-section of about 70° which is intended for illustrative purposes. Arcical cross-sections of wider or narrower dimension than specifically disclosed herein may serve to provide the intended and described novel functions of wick 12b and, as such, are considered to fall within the scope of this invention.
FIGS. 2a-b illustrate the stent of FIGS. 1a-d implanted within an obstructed duct 20 to aid in the drainage of fluids therethrough. When implanted, flaps 11a and 12a serve to anchor stent 10 in place within duct 20 and prevent undesirable migration. Drainage tube 13 maintains patency within duct 20, thereby allowing fluids to flow therethrough. Wick 12b provides a wicking effect which enhances the further flow of fluid upon exiting drainage tube 13 at outlet O, while also allowing sphincter 21 to function normally, thereby serving to reduce the possible occurrence of reflux.
The normal operation of sphincter 21 is illustrated by the comparison of FIGS. 2a and b. In FIG. 2a, sphincter 21 is opened to allow the free flow of fluid away from duct 20. In this state, wick 12b enhances drainage by providing a wicking effect for fluid as it exits the outflow end of drainage tube 13. In FIG. 2b, sphincter 21 is closed to prevent reflux from occurring. In this state, sphincter 21 closes about wick 12b to effectuate closure. When stent 10 is to be removed, wick 12b also serves the function of facilitating such removal by providing an exposed portion which is easily graspable by forceps or other instrument inserted for removal.
While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only the preferred embodiment has been shown and described and that all changes and modifications that come within the spirit of the invention are desired to be protected.

Claims (12)

What is claimed is:
1. A stent for facilitating the drainage of fluids through an obstructed duct within the body and through a sphincter at the exit of the obstructed duct while inhibiting reflux by allowing for the normal functioning of the sphincter, said stent comprising:
an inflow end portion, an outflow end portion, and a drainage tube therebetween, said inflow end portion defining inlet means for allowing fluid to enter into the inflow end of said drainage tube, said outflow end portion defining outlet means for allowing fluid to exit the outflow end of said drainage tube;
means for anchoring said stent in an obstructed duct with the inflow end of said drainage tube positioned within the duct; and
means for enhancing the drainage for fluid exiting said outlet means from within the duct while inhibiting reflux by allowing for the sphincter at the exit of the duct to function in a normal manner, said drainage enhancing/reflux inhibiting means including a wick extending from the outflow end of said drainage tube and comprising an extended arcical section of said drainage tube, whereby said wick enhances drainage by providing a wicking effect for fluid exiting said drainage tube while reducing the possible effect of reflux by allowing the sphincter at the exit of the duct to function in a normal manner.
2. The stent of claim 1 in which, when said stent has been implanted in a duct to be drained, said wick extends through the sphincter at the exit of the duct with said sphincter being allowed to function normally by closing about said wick, and further whereby said wick provides means for facilitating removal of said stent by providing an exposed portion of said stent which is easily graspable by an instrument inserted into the body for retention and removal.
3. The stent of claim 1 wherein the arcical cross-section of said wick is about 70°.
4. The stent of claim 1 in which said anchoring means includes radially extending flaps at each of said inflow end portion and said outflow end portion.
5. The stent of claim 2 in which said anchoring means includes radially extending flaps at each of said inflow end portion and said outflow end portion.
6. The stent of claim 2 in which said anchoring means includes multiple radially extending flaps at each of said inflow end portion and said outflow end portion.
7. The stent of claim 2 in which there are two rows of four equicircumferentially spaced radially extending flaps at said inflow end portion and one row of four equicircumferentially spaced radially extending flaps at said outflow end portion.
8. The stent of claim 1 wherein said drainage tube defines a continuously uninterrupted drainage lumen between said inflow end portion and said outflow end portion.
9. The stent of claim 2 wherein said drainage tube is defines a continuously uninterrupted drainage lumen between said inflow end portion and said outflow end portion. .Iadd.
10. A stent for facilitating the drainage of fluids through an obstructed duct within the body, said stent comprising:
an inflow end portion, an outflow end portion, and a drainage tube therebetween, said inflow end portion defining inlet means for allowing fluid to enter into the inflow end of said drainage tube, said outflow end portion defining outlet means for allowing fluid to exit the outflow end of said drainage tube; and
means for anchoring said stent in an obstructed duct with the inflow end of said drainage tube positioned within the duct;
wherein said anchoring means comprise a plurality of radially extending flaps formed by slicing small longitudinal sections in said drainage tube and orienting said sliced sections radially, and wherein said sliced sections are made shallowly such that holes are not made in said drainage tube. .Iaddend..Iadd.11. The stent of claim 10 wherein there are two rows of a first plurality of radially extending flaps at said inflow end portion and one row of a second plurality radially extending flaps at said outflow end portion. .Iaddend..Iadd.12. The stent of claim 10 wherein there are two rows of four equicircumferentially spaced radially extending flaps at said inflow end portion and one row of four equicircumferentially spaced radially extending flaps at said outflow end portion. .Iaddend..Iadd.13. A stent for facilitating the drainage of fluids through an obstructed duct within the body, said stent comprising:
an inflow end portion, an outflow end portion, and a drainage tube therebetween, said inflow end portion defining inlet means for allowing fluid to enter into the inflow end of said drainage tube, said outflow end portion defining outlet means for allowing fluid to exit the outflow end of said drainage tube; and
means for anchoring said stent in an obstructed duct with the inflow end of said drainage tube positioned within the duct;
wherein said anchoring means comprise a plurality of radially extending flaps formed by slicing small longitudinal sections in said drainage tube and orienting said sliced sections radially, and wherein said drainage tube defines a continuously uninterrupted drainage lumen between said
inflow end portion and said outflow end portion. .Iaddend..Iadd.14. A stent for facilitating the drainage of fluids through an obstructed duct within the body, said stent comprising:
an inflow end portion, an outflow end portion, and a drainage tube therebetween, said inflow end portion defining inlet means for allowing fluid to enter into the inflow end of said drainage tube, said outflow end portion defining outlet means for allowing fluid to exit the outflow end of said drainage tube; and
means for anchoring said stent in an obstructed duct with the inflow end of said drainage tube positioned within the duct;
wherein said anchoring means comprise two rows of a first plurality of radially extending flaps at said inflow end portion and one row of a second plurality of radially extending flaps at said outflow end portion, and wherein said flaps are formed by slicing small longitudinal sections in said drainage tube such that one end of each flap is severed from drainage tube. .Iaddend..Iadd.15. The stent of claim 14 wherein said flaps are formed by orienting said sliced sections radially. .Iaddend..Iadd.16. A stent for facilitating the drainage of fluids through an obstructed duct within the body, said stent comprising:
an inflow end portion, an outflow end portion, and a drainage tube therebetween, said inflow end portion defining inlet means for allowing fluid to enter into the inflow end of said drainage tube, said outflow end portion defining outlet means for allowing fluid to exit the outflow end of said drainage tube; and
means for anchoring said stent in an obstructed duct with the inflow end of said drainage tube positioned within the duct;
wherein said anchoring means comprise two rows of a first plurality of radially extending flaps at said inflow end portion and one row of a second plurality of radially extending flaps at said outflow end portion;
wherein said flaps are formed by a small longitudinal sections in said drainage tube and orienting said sliced sections radially, and wherein said sliced sections are made shallowly such that holes are not made in
said drainage tube. .Iaddend..Iadd.17. The stent of claim 14 wherein said first plurality of flaps comprise two rows of four equicircumferentially spaced flaps and said second plurality of flaps comprise one row of four equicircumferentially spaced flaps. .Iaddend..Iadd.18. A stent for facilitating the drainage of fluids through an obstructed duct within the body, said stent comprising:
an inflow end portion, an outflow end portion, and a drainage tube therebetween, said inflow end portion defining inlet means for allowing fluid to enter into the inflow end of said drainage tube, said outflow end portion defining outlet means for allowing fluid to exit the outflow end of said drainage tube; and
means for anchoring said stent in an obstructed duct with the inflow end of said drainage tube positioned within the duct;
wherein said anchoring means comprise two rows of a first plurality of radially extending flaps at said inflow end portion and one row of a second plurality of radially extending flaps at said outflow end portion; and
wherein said drainage tube defines a continuously uninterrupted drainage lumen between said inflow end portion and said outflow end portion. .Iaddend.
US08/367,801 1992-01-15 1994-12-30 Indwelling stent Expired - Lifetime USRE35849E (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US08/367,801 USRE35849E (en) 1992-01-15 1994-12-30 Indwelling stent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/821,001 US5176626A (en) 1992-01-15 1992-01-15 Indwelling stent
US08/367,801 USRE35849E (en) 1992-01-15 1994-12-30 Indwelling stent

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US07/821,001 Reissue US5176626A (en) 1992-01-15 1992-01-15 Indwelling stent

Publications (1)

Publication Number Publication Date
USRE35849E true USRE35849E (en) 1998-07-14

Family

ID=25232246

Family Applications (2)

Application Number Title Priority Date Filing Date
US07/821,001 Ceased US5176626A (en) 1992-01-15 1992-01-15 Indwelling stent
US08/367,801 Expired - Lifetime USRE35849E (en) 1992-01-15 1994-12-30 Indwelling stent

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US07/821,001 Ceased US5176626A (en) 1992-01-15 1992-01-15 Indwelling stent

Country Status (1)

Country Link
US (2) US5176626A (en)

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020107540A1 (en) * 2001-01-23 2002-08-08 Whalen Mark J. Endourethral device & method
US20030018307A1 (en) * 1997-12-12 2003-01-23 Boris Reydel Body canal intrusion instrumentation having bidirectional coefficient of surface friction with body tissue
US20030060894A1 (en) * 1998-08-31 2003-03-27 Dua Kulwinders S. Prosthesis having a sleeve valve
US20030078467A1 (en) * 2001-10-18 2003-04-24 Whalen Mark J. Endourethral device & method
US20030208183A1 (en) * 2000-08-07 2003-11-06 Whalen Mark J. Endourethral device & method
US6666883B1 (en) 1996-06-06 2003-12-23 Jacques Seguin Endoprosthesis for vascular bifurcation
US20040015155A1 (en) * 1999-12-01 2004-01-22 Abbeymoor Medical, Inc. Magnetic retrieval device and method of use
US20040024362A1 (en) * 2002-04-11 2004-02-05 Hugh Trout Stabilizing surgical delivery apparatus and method of use
US20040193092A1 (en) * 2003-03-26 2004-09-30 Scimed Life Systems, Inc. Self-retaining stent
US20040199262A1 (en) * 1998-08-31 2004-10-07 Wilson-Cook Medical Incorporated Prosthesis having a sleeve valve
US20040254602A1 (en) * 2003-03-28 2004-12-16 Lehe Cathleen Von Double ended intravascular medical device
US20050107721A1 (en) * 2000-08-31 2005-05-19 Abbeymoor Medical, Inc. Diagnostic urethral assembly & method
US7001327B2 (en) 2000-02-01 2006-02-21 Abbeymoor Medical, Inc. Urinary flow control device and method
US7041139B2 (en) 2001-12-11 2006-05-09 Boston Scientific Scimed, Inc. Ureteral stents and related methods
US7048698B2 (en) 2001-06-22 2006-05-23 Abbeymoor Medical, Inc. Urethral profiling device and methodology
WO2006124108A1 (en) * 2005-05-11 2006-11-23 Boston Scientific Scimed, Inc. Ureteral stent with conforming retention structure
US20070016306A1 (en) * 1998-08-31 2007-01-18 Wilson-Cook Medical Inc. Prosthesis having a sleeve valve
US7211114B2 (en) 2002-08-26 2007-05-01 The Trustees Of Columbia University In The City Of New York Endoscopic gastric bypass
US20080051911A1 (en) * 2006-08-23 2008-02-28 Wilson-Cook Medical Inc. Stent with antimicrobial drainage lumen surface
US20080086214A1 (en) * 1998-08-31 2008-04-10 Wilson-Cook Medical Inc. Medical device having a sleeve valve with bioactive agent
US20080208314A1 (en) * 2007-02-22 2008-08-28 Wilson-Cook Medical Inc. Prosthesis having a sleeve valve
US20080228126A1 (en) * 2006-03-23 2008-09-18 The Trustees Of Columbia University In The City Of New York Method of inhibiting disruption of the healing process in a physically modified stomach
US20090048654A1 (en) * 2007-08-15 2009-02-19 Wilson-Cook Medical Inc. Deployment System for Soft Stents
US20090093822A1 (en) * 2007-10-03 2009-04-09 Wilson-Cook Medical Inc. Magnetic stent removal
US20110087252A1 (en) * 2009-10-08 2011-04-14 Wilson-Cook Medical Inc. Biliary decompression and anastomosis stent
WO2011023929A3 (en) * 2009-08-24 2011-08-18 Alternative Urological Catheter Systems Limited Suprapubic urethral catheters
US20110224775A1 (en) * 2010-03-11 2011-09-15 Wilson-Cook Medical Inc. Stent Geometry
US20130066328A1 (en) * 2011-04-07 2013-03-14 Jai Singh General uterine manipulator and system
US20130197536A1 (en) * 2011-04-07 2013-08-01 Jai Singh General uterine manipulator and system
US8574221B2 (en) 2011-09-09 2013-11-05 Cook Medical Technologies Llc Tubular medical device
US8740876B2 (en) 2010-05-10 2014-06-03 Cook Medical Technologies Llc Device for external percutaneous connections
US20160081717A1 (en) * 2011-04-07 2016-03-24 Jai Singh General uterine manipulator and system
US9532837B2 (en) 2012-04-20 2017-01-03 Jiwan Steven Singh Repositionable medical instrument support systems, devices, and methods

Families Citing this family (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5782903A (en) * 1987-10-19 1998-07-21 Medtronic, Inc. Intravascular stent and method
US5549559A (en) 1990-03-22 1996-08-27 Argomed Ltd. Thermal treatment apparatus
US6576008B2 (en) * 1993-02-19 2003-06-10 Scimed Life Systems, Inc. Methods and device for inserting and withdrawing a two piece stent across a constricting anatomic structure
FR2701648B1 (en) * 1993-02-19 1995-03-31 Marian Devonec Prosthesis intended for the treatment of a light or natural way, in particular endo-urethral prosthesis.
DK0797988T3 (en) * 1993-07-19 2009-05-11 Univ British Columbia Anti-angiogenic compositions and methods for their use
US5486191A (en) * 1994-02-02 1996-01-23 John Hopkins University Winged biliary stent
US6849063B1 (en) 1994-03-11 2005-02-01 Wit Ip Corporation Thermal treatment apparatus
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US6676623B2 (en) 2001-05-04 2004-01-13 Scimed Life Systems, Inc. Drainage devices and methods
US6991614B2 (en) * 1995-11-07 2006-01-31 Boston Scientific Scimed, Inc. Ureteral stent for improved patient comfort
US6849069B1 (en) * 1995-11-07 2005-02-01 Boston Scientitfic Corporation Medical device with tail(s) for assisting flow of urine
JPH1057496A (en) * 1996-06-14 1998-03-03 Olympus Optical Co Ltd Indwelling tube for medical use
US6059757A (en) * 1996-06-18 2000-05-09 Cardeon Single lumen catheter with controlled antegrade and retrograde flow
US5795319A (en) * 1997-03-07 1998-08-18 Circon Corporation Easily removable ureteral stent
US6197324B1 (en) 1997-12-18 2001-03-06 C. R. Bard, Inc. System and methods for local delivery of an agent
US6251418B1 (en) * 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
US6893430B2 (en) 1998-02-04 2005-05-17 Wit Ip Corporation Urethral catheter and guide
US6196230B1 (en) 1998-09-10 2001-03-06 Percardia, Inc. Stent delivery system and method of use
JP2003534822A (en) * 1998-09-10 2003-11-25 パーカーディア,インコーポレイティド Implantable shunt device
US6689121B1 (en) 1998-09-24 2004-02-10 C. R. Bard, Inc. Systems and methods for treating ischemia
US6458092B1 (en) 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
US6248112B1 (en) 1998-09-30 2001-06-19 C. R. Bard, Inc. Implant delivery system
US6432126B1 (en) 1998-09-30 2002-08-13 C.R. Bard, Inc. Flexible vascular inducing implants
US8480610B1 (en) * 1998-12-08 2013-07-09 Frank C. Hill Ear tube and method of insertion
US6692520B1 (en) 1998-12-15 2004-02-17 C. R. Bard, Inc. Systems and methods for imbedded intramuscular implants
US6332892B1 (en) 1999-03-02 2001-12-25 Scimed Life Systems, Inc. Medical device with one or more helical coils
US6162237A (en) * 1999-04-19 2000-12-19 Chan; Winston Kam Yew Temporary intravascular stent for use in retrohepatic IVC or hepatic vein injury
US6986784B1 (en) 1999-05-14 2006-01-17 C. R. Bard, Inc. Implant anchor systems
JP4108882B2 (en) 1999-08-04 2008-06-25 オリンパス株式会社 Endoscope wall fixture
US6855160B1 (en) 1999-08-04 2005-02-15 C. R. Bard, Inc. Implant and agent delivery device
US6547761B2 (en) 2000-01-07 2003-04-15 Scimed Life Systems, Inc. Drainage catheter
US7232421B1 (en) 2000-05-12 2007-06-19 C. R. Bard, Inc. Agent delivery systems
US6764519B2 (en) 2000-05-26 2004-07-20 Scimed Life Systems, Inc. Ureteral stent
US6716252B2 (en) 2000-06-30 2004-04-06 Wit Ip Corporation Prostatic stent with localized tissue engaging anchoring means and methods for inhibiting obstruction of the prostatic urethra
US7204847B1 (en) 2000-07-28 2007-04-17 C. R. Bard, Inc. Implant anchor systems
DE10115740A1 (en) * 2001-03-26 2002-10-02 Ulrich Speck Preparation for restenosis prophylaxis
US6719804B2 (en) 2001-04-02 2004-04-13 Scimed Life Systems, Inc. Medical stent and related methods
US6494855B2 (en) 2001-05-16 2002-12-17 Scimed Life Systems, Inc. Draining bodily fluid
US6981964B2 (en) 2001-05-22 2006-01-03 Boston Scientific Scimed, Inc. Draining bodily fluids with a stent
US6790223B2 (en) 2001-09-21 2004-09-14 Scimed Life Systems, Inc. Delivering a uretheral stent
JP4043210B2 (en) * 2001-10-09 2008-02-06 オリンパス株式会社 Stent
US6620202B2 (en) * 2001-10-16 2003-09-16 Scimed Life Systems, Inc. Medical stent with variable coil and related methods
JP4043216B2 (en) * 2001-10-30 2008-02-06 オリンパス株式会社 Stent
DE10159708A1 (en) * 2001-12-05 2003-06-18 Bayer Ag Alkaline chloride electrolysis cell with gas diffusion electrodes
US20040068314A1 (en) * 2002-01-16 2004-04-08 Jones Donald K. Detachable self -expanding aneurysm cover device
US6913625B2 (en) 2002-03-07 2005-07-05 Scimed Life Systems, Inc. Ureteral stent
ES2555307T3 (en) 2002-03-08 2015-12-30 Eisai R&D Management Co., Ltd. Macrocyclic compounds useful as pharmaceutical agents
US8328877B2 (en) * 2002-03-19 2012-12-11 Boston Scientific Scimed, Inc. Stent retention element and related methods
PL219737B1 (en) 2002-03-22 2015-07-31 Eisai R & D Man Co Hrmiasterlin derivatives and uses thereof
US6949125B2 (en) * 2002-04-16 2005-09-27 Boston Scientific Scimed, Inc. Ureteral stent with end-effector and related methods
US7485150B2 (en) * 2002-04-23 2009-02-03 Boston Scientific Scimed, Inc. Drainage devices and methods
DE10244847A1 (en) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medical device for drug delivery
US6733536B1 (en) * 2002-10-22 2004-05-11 Scimed Life Systems Male urethral stent device
US7182745B2 (en) * 2003-03-25 2007-02-27 Boston Scientific Scimed, Inc. Retaining stent
US6929663B2 (en) * 2003-03-26 2005-08-16 Boston Scientific Scimed, Inc. Longitudinally expanding medical device
US7651529B2 (en) * 2003-05-09 2010-01-26 Boston Scientific Scimed, Inc. Stricture retractor
US8876882B2 (en) * 2003-10-10 2014-11-04 Mark Gelido Barongan Cutting stent
US7338530B2 (en) * 2003-11-24 2008-03-04 Checkmed Systems, Inc. Stent
US20050240141A1 (en) * 2004-04-26 2005-10-27 Peter Aliski Stent kidney curl improvements
US7470247B2 (en) * 2004-04-26 2008-12-30 Gyrus Acmi, Inc. Ureteral stent
US7507218B2 (en) * 2004-04-26 2009-03-24 Gyrus Acmi, Inc. Stent with flexible elements
US8410246B2 (en) 2004-06-17 2013-04-02 Thrasos, Inc. TDF-related compounds and analogs thereof
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
CN103259027A (en) 2005-04-28 2013-08-21 普罗透斯数字保健公司 Pharma-informatics system
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8547248B2 (en) * 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
SI2497780T1 (en) 2005-09-20 2015-08-31 Thrasos Innovation, Inc. TDF-related compounds and analogs thereof
CN105468895A (en) 2006-05-02 2016-04-06 普罗透斯数字保健公司 Patient customized therapeutic regimens
AU2007267695A1 (en) * 2006-05-23 2007-12-06 Entrigue Surgical, Inc. Sinus tube
WO2008006097A2 (en) * 2006-07-07 2008-01-10 Intezyne Technologies Llc Covalent modification of metal surfaces
US8054140B2 (en) * 2006-10-17 2011-11-08 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
SG175681A1 (en) 2006-10-25 2011-11-28 Proteus Biomedical Inc Controlled activation ingestible identifier
EP2069004A4 (en) 2006-11-20 2014-07-09 Proteus Digital Health Inc Active signal processing personal health signal receivers
CN101686800A (en) 2007-02-01 2010-03-31 普罗秋斯生物医学公司 Ingestible event marker systems
CA2676280C (en) 2007-02-14 2018-05-22 Proteus Biomedical, Inc. In-body power source having high surface area electrode
EP2063771A1 (en) 2007-03-09 2009-06-03 Proteus Biomedical, Inc. In-body device having a deployable antenna
EP2124725A1 (en) * 2007-03-09 2009-12-02 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US8115618B2 (en) * 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
EP2192946B1 (en) 2007-09-25 2022-09-14 Otsuka Pharmaceutical Co., Ltd. In-body device with virtual dipole signal amplification
EP2215726B1 (en) 2007-11-27 2018-01-10 Proteus Digital Health, Inc. Transbody communication systems employing communication channels
SG188839A1 (en) * 2008-03-05 2013-04-30 Proteus Digital Health Inc Multi-mode communication ingestible event markers and systems, and methods of using the same
US11207199B2 (en) * 2008-06-11 2021-12-28 Q3 Medical Devices Limited Stent with anti-migration devices
AU2009268827B2 (en) * 2008-07-08 2013-10-24 Proteus Digital Health, Inc. Ingestible event marker data framework
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
CN102246198A (en) * 2008-10-14 2011-11-16 普罗秋斯生物医学公司 Method and system for incorporating physiologic data in a gaming environment
US20100100170A1 (en) 2008-10-22 2010-04-22 Boston Scientific Scimed, Inc. Shape memory tubular stent with grooves
AU2009313879B2 (en) * 2008-11-13 2011-10-20 Proteus Digital Health, Inc. Ingestible therapy activator system and method
CN102271578B (en) 2008-12-11 2013-12-04 普罗秋斯数字健康公司 Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US8192500B2 (en) 2008-12-12 2012-06-05 Boston Scientific Scimed, Inc. Ureteral stent
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
TWI424832B (en) * 2008-12-15 2014-02-01 Proteus Digital Health Inc Body-associated receiver and method
US8512272B2 (en) 2008-12-22 2013-08-20 Boston Scientific Scimed, Inc. Ureteral stent
KR20110104079A (en) 2009-01-06 2011-09-21 프로테우스 바이오메디컬, 인코포레이티드 Pharmaceutical dosages delivery system
CA2750158A1 (en) 2009-01-06 2010-07-15 Proteus Biomedical, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
GB2480965B (en) 2009-03-25 2014-10-08 Proteus Digital Health Inc Probablistic pharmacokinetic and pharmacodynamic modeling
EP3906845A1 (en) * 2009-04-28 2021-11-10 Otsuka Pharmaceutical Co., Ltd. Highly reliable ingestible event markers
EP2432458A4 (en) 2009-05-12 2014-02-12 Proteus Digital Health Inc Ingestible event markers comprising an ingestible component
AU2010256450B2 (en) * 2009-06-05 2014-09-18 Arthrocare Corporation Systems and devices for providing therapy of an anatomical structure
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US20110054448A1 (en) * 2009-08-28 2011-03-03 Navilyst Medical, Inc. Medical device containing catheter anchoring feature
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
UA109424C2 (en) 2009-12-02 2015-08-25 PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS
JP5841951B2 (en) 2010-02-01 2016-01-13 プロテウス デジタル ヘルス, インコーポレイテッド Data collection system
SG184494A1 (en) 2010-04-07 2012-11-29 Proteus Biomedical Inc Miniature ingestible device
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
JP2014504902A (en) 2010-11-22 2014-02-27 プロテウス デジタル ヘルス, インコーポレイテッド Ingestible device with medicinal product
JP2014514032A (en) 2011-03-11 2014-06-19 プロテウス デジタル ヘルス, インコーポレイテッド Wearable personal body-related devices with various physical configurations
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
EP2734973A4 (en) 2011-07-21 2015-07-01 Proteus Digital Health Inc Mobile communication device, system, and method
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
AU2013293234B2 (en) 2012-07-23 2017-08-31 Otsuka Pharmaceutical Co., Ltd. Techniques for manufacturing ingestible event markers comprising an ingestible component
WO2014062674A1 (en) 2012-10-18 2014-04-24 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
ES2472122B1 (en) * 2012-12-27 2015-04-13 Fundación Centro De Cirugía Mínima Invasión Jesús Usón Self-retentive and anti-reflux ureteral catheter
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
JP6498177B2 (en) 2013-03-15 2019-04-10 プロテウス デジタル ヘルス, インコーポレイテッド Identity authentication system and method
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
CA2924815C (en) 2013-09-20 2017-06-20 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
WO2015044722A1 (en) 2013-09-24 2015-04-02 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
AU2015243533A1 (en) * 2014-04-10 2016-10-27 C.R. Bard, Inc. Ureteral stents
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
KR102215238B1 (en) 2016-07-22 2021-02-22 프로테우스 디지털 헬스, 인코포레이티드 Electromagnetic sensing and detection of ingestible event markers
WO2018081337A1 (en) 2016-10-26 2018-05-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3690323A (en) * 1970-12-01 1972-09-12 Us Army Device for draining ventricular fluid in cases of hydrocephalus
US3938529A (en) * 1974-07-22 1976-02-17 Gibbons Robert P Indwelling ureteral catheter
US4382445A (en) * 1980-12-04 1983-05-10 Cosmos Research Associates Physiological fluid shunt system and improvements therefor
US4474569A (en) * 1982-06-28 1984-10-02 Denver Surgical Developments, Inc. Antenatal shunt
US4671795A (en) * 1984-11-19 1987-06-09 Mulchin William L Permanent/retrievable ureteral catheter
US4767400A (en) * 1987-10-27 1988-08-30 Cordis Corporation Porous ventricular catheter
US4913683A (en) * 1988-07-05 1990-04-03 Medical Engineering Corporation Infusion stent system
US4955859A (en) * 1989-07-07 1990-09-11 C. R. Bard, Inc. High-friction prostatic stent
US4973301A (en) * 1989-07-11 1990-11-27 Israel Nissenkorn Catheter and method of using same
US5019102A (en) * 1987-12-10 1991-05-28 Eberhard Hoene Anti-refluxive internal ureteral stent with a dynamic hood-valve at the vesical end for prevention of urinary reflux into the upper urinary tract upon increase of vesical pressure
US5052998A (en) * 1990-04-04 1991-10-01 Zimmon David S Indwelling stent and method of use
US5059169A (en) * 1989-07-07 1991-10-22 C. R. Bard, Inc. High-friction prostatic stent
US5167614A (en) * 1991-10-29 1992-12-01 Medical Engineering Corporation Prostatic stent

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3690323A (en) * 1970-12-01 1972-09-12 Us Army Device for draining ventricular fluid in cases of hydrocephalus
US3938529A (en) * 1974-07-22 1976-02-17 Gibbons Robert P Indwelling ureteral catheter
US4382445A (en) * 1980-12-04 1983-05-10 Cosmos Research Associates Physiological fluid shunt system and improvements therefor
US4474569A (en) * 1982-06-28 1984-10-02 Denver Surgical Developments, Inc. Antenatal shunt
US4671795A (en) * 1984-11-19 1987-06-09 Mulchin William L Permanent/retrievable ureteral catheter
US4767400A (en) * 1987-10-27 1988-08-30 Cordis Corporation Porous ventricular catheter
US5019102A (en) * 1987-12-10 1991-05-28 Eberhard Hoene Anti-refluxive internal ureteral stent with a dynamic hood-valve at the vesical end for prevention of urinary reflux into the upper urinary tract upon increase of vesical pressure
US4913683A (en) * 1988-07-05 1990-04-03 Medical Engineering Corporation Infusion stent system
US4955859A (en) * 1989-07-07 1990-09-11 C. R. Bard, Inc. High-friction prostatic stent
US5059169A (en) * 1989-07-07 1991-10-22 C. R. Bard, Inc. High-friction prostatic stent
US4973301A (en) * 1989-07-11 1990-11-27 Israel Nissenkorn Catheter and method of using same
US5052998A (en) * 1990-04-04 1991-10-01 Zimmon David S Indwelling stent and method of use
US5167614A (en) * 1991-10-29 1992-12-01 Medical Engineering Corporation Prostatic stent

Cited By (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6666883B1 (en) 1996-06-06 2003-12-23 Jacques Seguin Endoprosthesis for vascular bifurcation
US20030018307A1 (en) * 1997-12-12 2003-01-23 Boris Reydel Body canal intrusion instrumentation having bidirectional coefficient of surface friction with body tissue
US6767339B2 (en) * 1997-12-12 2004-07-27 Wilson-Cook Medical, Inc. Body canal intrusion instrumentation having bidirectional coefficient of surface friction with body tissue
US20080086214A1 (en) * 1998-08-31 2008-04-10 Wilson-Cook Medical Inc. Medical device having a sleeve valve with bioactive agent
US20030060894A1 (en) * 1998-08-31 2003-03-27 Dua Kulwinders S. Prosthesis having a sleeve valve
US20040199262A1 (en) * 1998-08-31 2004-10-07 Wilson-Cook Medical Incorporated Prosthesis having a sleeve valve
US20070016306A1 (en) * 1998-08-31 2007-01-18 Wilson-Cook Medical Inc. Prosthesis having a sleeve valve
US20040015155A1 (en) * 1999-12-01 2004-01-22 Abbeymoor Medical, Inc. Magnetic retrieval device and method of use
US7001327B2 (en) 2000-02-01 2006-02-21 Abbeymoor Medical, Inc. Urinary flow control device and method
US20070078389A1 (en) * 2000-08-07 2007-04-05 Whalen Mark J Endourethral device & method
US20030208183A1 (en) * 2000-08-07 2003-11-06 Whalen Mark J. Endourethral device & method
US7141038B2 (en) 2000-08-07 2006-11-28 Abbeymoor Medical, Inc. Endourethral device and method
US7758542B2 (en) 2000-08-07 2010-07-20 Abbeymoor Medical, Inc. Endourethral device and method
US20050107721A1 (en) * 2000-08-31 2005-05-19 Abbeymoor Medical, Inc. Diagnostic urethral assembly & method
US20060116547A1 (en) * 2001-01-23 2006-06-01 Abbeymoor Medical, Inc. Endourethral device & method
US8016742B2 (en) 2001-01-23 2011-09-13 Abbeymoor Medical, Inc. Endourethral device and method
US20020107540A1 (en) * 2001-01-23 2002-08-08 Whalen Mark J. Endourethral device & method
EP1392388A2 (en) * 2001-01-23 2004-03-03 Abbeymoor Medical, Inc. Endourethral device & method
EP1392388A4 (en) * 2001-01-23 2007-01-17 Abbeymoor Medical Inc Endourethral device & method
US20060287570A1 (en) * 2001-01-23 2006-12-21 Abbeymoor Medical, Inc. Endourethral device & method
US7951064B2 (en) 2001-01-23 2011-05-31 Abbeymoor Medical, Inc. Endourethral device and method
US20060195008A1 (en) * 2001-01-23 2006-08-31 Abbeymoor Medical, Inc. Endourethral device & method
US7108655B2 (en) 2001-01-23 2006-09-19 Abbeymoor Medical, Inc. Endourethral device and method
US7048698B2 (en) 2001-06-22 2006-05-23 Abbeymoor Medical, Inc. Urethral profiling device and methodology
EP1411867B1 (en) * 2001-07-31 2010-03-31 Wilson-Cook Medical Inc. Prosthesis having a sleeve valve
EP1411867A2 (en) * 2001-07-31 2004-04-28 Wilson-Cook Medical Inc. Prosthesis having a sleeve valve
US20030078467A1 (en) * 2001-10-18 2003-04-24 Whalen Mark J. Endourethral device & method
US6991596B2 (en) 2001-10-18 2006-01-31 Abbeymoor Medical, Inc. Endourethral device and method
US7041139B2 (en) 2001-12-11 2006-05-09 Boston Scientific Scimed, Inc. Ureteral stents and related methods
US20040024362A1 (en) * 2002-04-11 2004-02-05 Hugh Trout Stabilizing surgical delivery apparatus and method of use
US7211114B2 (en) 2002-08-26 2007-05-01 The Trustees Of Columbia University In The City Of New York Endoscopic gastric bypass
US7837645B2 (en) 2002-08-26 2010-11-23 The Trustees Of Columbia University In The City Of New York Endoscopic gastric bypass
US7357818B2 (en) 2003-03-26 2008-04-15 Boston Scientific Scimed, Inc. Self-retaining stent
US8057461B2 (en) 2003-03-26 2011-11-15 Boston Scientific Scimed, Inc. Self-retaining stent
US20040193092A1 (en) * 2003-03-26 2004-09-30 Scimed Life Systems, Inc. Self-retaining stent
WO2004087248A1 (en) * 2003-03-26 2004-10-14 Scimed Life Systems, Inc. Self-retaining stent
US9820845B2 (en) 2003-03-28 2017-11-21 Covidien Lp Holding zone for intravascular medical device
US9220873B2 (en) 2003-03-28 2015-12-29 Covidien Lp Double ended intravascular medical device
US8435256B2 (en) 2003-03-28 2013-05-07 Covidien Lp Double ended intravascular medical device
US20040254602A1 (en) * 2003-03-28 2004-12-16 Lehe Cathleen Von Double ended intravascular medical device
US7637920B2 (en) 2003-03-28 2009-12-29 Ev3 Inc. Double ended intravascular medical device
US20100063536A1 (en) * 2003-03-28 2010-03-11 Ev3 Inc. Double ended intravascular medical device
US10660737B2 (en) 2003-03-28 2020-05-26 Covidien Lp Double ended intravascular medical device
US8252065B2 (en) 2005-05-11 2012-08-28 Boston Scientific Scimed, Inc. Ureteral stent with conforming retention structure
US7396366B2 (en) 2005-05-11 2008-07-08 Boston Scientific Scimed, Inc. Ureteral stent with conforming retention structure
US7722677B2 (en) 2005-05-11 2010-05-25 Boston Scientific Scimed, Inc. Ureteral stent with conforming retention structure
WO2006124108A1 (en) * 2005-05-11 2006-11-23 Boston Scientific Scimed, Inc. Ureteral stent with conforming retention structure
US20100198359A1 (en) * 2005-05-11 2010-08-05 Boston Scientific Scimed, Inc. Ureteral stent with conforming retention structure
US20080228126A1 (en) * 2006-03-23 2008-09-18 The Trustees Of Columbia University In The City Of New York Method of inhibiting disruption of the healing process in a physically modified stomach
US20080051911A1 (en) * 2006-08-23 2008-02-28 Wilson-Cook Medical Inc. Stent with antimicrobial drainage lumen surface
US8221505B2 (en) 2007-02-22 2012-07-17 Cook Medical Technologies Llc Prosthesis having a sleeve valve
US20080208314A1 (en) * 2007-02-22 2008-08-28 Wilson-Cook Medical Inc. Prosthesis having a sleeve valve
US20090048654A1 (en) * 2007-08-15 2009-02-19 Wilson-Cook Medical Inc. Deployment System for Soft Stents
US8066715B2 (en) 2007-10-03 2011-11-29 Cook Medical Technologies Llc Magnetic stent removal
US20090093822A1 (en) * 2007-10-03 2009-04-09 Wilson-Cook Medical Inc. Magnetic stent removal
WO2011023929A3 (en) * 2009-08-24 2011-08-18 Alternative Urological Catheter Systems Limited Suprapubic urethral catheters
US20110087252A1 (en) * 2009-10-08 2011-04-14 Wilson-Cook Medical Inc. Biliary decompression and anastomosis stent
US8845663B2 (en) 2009-10-08 2014-09-30 Cook Medical Technologies Llc Biliary decompression and anastomosis stent
US8603185B2 (en) 2010-03-11 2013-12-10 Cook Medical Technologies Llc Stent geometry
US20110224775A1 (en) * 2010-03-11 2011-09-15 Wilson-Cook Medical Inc. Stent Geometry
US8740876B2 (en) 2010-05-10 2014-06-03 Cook Medical Technologies Llc Device for external percutaneous connections
US9451985B2 (en) 2011-04-07 2016-09-27 Jiwan Steven Singh General uterine manipulator and system
US9101390B2 (en) * 2011-04-07 2015-08-11 Jai Singh General uterine manipulator and system
US20130197536A1 (en) * 2011-04-07 2013-08-01 Jai Singh General uterine manipulator and system
US20160081717A1 (en) * 2011-04-07 2016-03-24 Jai Singh General uterine manipulator and system
US20150012009A1 (en) * 2011-04-07 2015-01-08 Jai Singh General uterine manipulator and system
US20130066328A1 (en) * 2011-04-07 2013-03-14 Jai Singh General uterine manipulator and system
US9974567B2 (en) 2011-04-07 2018-05-22 Jiwan Steven Singh General uterine manipulator and system
US9987042B2 (en) * 2011-04-07 2018-06-05 Jai Singh General uterine manipulator and system
US10792072B2 (en) 2011-04-07 2020-10-06 Jai Singh General uterine manipulator and system
US8574221B2 (en) 2011-09-09 2013-11-05 Cook Medical Technologies Llc Tubular medical device
US9532837B2 (en) 2012-04-20 2017-01-03 Jiwan Steven Singh Repositionable medical instrument support systems, devices, and methods
US10004569B2 (en) 2012-04-20 2018-06-26 Jiwan Steven Singh Repositionable medical instrument support systems, devices, and methods

Also Published As

Publication number Publication date
US5176626A (en) 1993-01-05

Similar Documents

Publication Publication Date Title
USRE35849E (en) Indwelling stent
EP0373178B1 (en) Antireflux ureteral duct with dynamic hood valve at the vesical end
US10500073B2 (en) Ureteral stent for placement in a kidney and bladder
US5738654A (en) Self cleansing bladder drainage device
EP3129097B1 (en) Ureteral stents
EP1482862B1 (en) Ureteral stent
DE69633385T2 (en) HARN TUBE STAND VARIABLE LENGTH
US6929664B2 (en) Open lumen stents
ES2547355T3 (en) Implant to regulate a flow
US6743198B1 (en) Self-cleansing bladder drainage device
DE69731027T2 (en) Antirefluxive ureteral stent
US7112226B2 (en) Male urethral stent device
US20030163204A1 (en) Stent
US20150127115A1 (en) Open lumen stent
WO1999063896A3 (en) Aneurysm closure device assembly
DE60130895T2 (en) HARN CATHETER WITHOUT BALLOON
EP3089780A1 (en) An incising implant for the prostatic urethra
SE454050B (en) DRAIN FOR DIRECTORS
CA2476738A1 (en) Anti-reflux ureteral stents and methods
CA2310558C (en) Self-cleansing bladder drainage device
US10398541B2 (en) System and method for use of flexible anti-reflux ureteral stent
CA2191814A1 (en) Self-cleansing bladder drainage device

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: COOK MEDICAL TECHNOLOGIES LLC, INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:COOK INCORPORATED;WILSON-COOK MEDICAL INCORPORATED;VANCE PRODUCTS INCORPORATED;AND OTHERS;SIGNING DATES FROM 20110315 TO 20110322;REEL/FRAME:026287/0923